Literature DB >> 11575867

Cognitive and motor function in patients with Parkinson's disease with and without depression.

E Cubo1, B Bernard, S Leurgans, R Raman.   

Abstract

The objective of this study was to define risk factors for depression in patients with idiopathic Parkinson's disease (PD) and to evaluate the correlation of depression with cognitive function and the primary domains of parkinsonian motor dysfunction tremor, bradykinesia, rigidity, gait and balance impairment. The risk factors for depression in patients with PD remain controversial. Several investigators have demonstrated a significant association between cognitive dysfunction and depression, but motoric and disease variables can confound this evaluation and have shown an inconsistent relation to depression. A consecutive series of 88 patients with PD were examined using the motor subscale of the Unified Parkinson's Disease Rating Scale (UPDRSm), Hoehn-Yahr stage (HY), and Hamilton Rating Scale for Depression (HRSD). Major depression was diagnosed according to the criteria in the Diagnostic and Statistic Manual of Mental Disorders, 4th edition. Gender, age, handedness, PD duration, side of PD onset, motor fluctuations, UPDRSm total score, daily Levodopa dose, and Mini-Mental State Examination score (MMSE) were analyzed using multivariate and univariate logistic regression, Fisher's Exact test, and Pearson correlations. Major depression was diagnosed in 12 patients (7.3%). Low MMSE score, axial bradykinesia, gait and balance impairment were strongly significant predictors of depression. In conclusion, depression and physical function are important factors impairing the quality of life for patients with PD, and regular depression screening and treatment should focus on patients with PD who have cognitive impairment, high axial bradykinesia, gait and balance impairment.

Entities:  

Mesh:

Year:  2000        PMID: 11575867     DOI: 10.1097/00002826-200011000-00006

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  16 in total

1.  Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia.

Authors:  Gabriella Santangelo; Carmine Vitale; Luigi Trojano; Katia Longo; Autilia Cozzolino; Dario Grossi; Paolo Barone
Journal:  J Neurol       Date:  2009-04-15       Impact factor: 4.849

Review 2.  Anxiety in Parkinson's disease: identification and management.

Authors:  Jack J Chen; Laura Marsh
Journal:  Ther Adv Neurol Disord       Date:  2014-01       Impact factor: 6.570

3.  Depression in Parkinson's disease.

Authors:  Barbara Jasinska-Myga; John D Putzke; Christian Wider; Zbigniew K Wszolek; Ryan J Uitti
Journal:  Can J Neurol Sci       Date:  2010-01       Impact factor: 2.104

Review 4.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

5.  Clinical correlates of depressive symptoms in familial Parkinson's disease.

Authors:  Nathan Pankratz; Karen S Marder; Cheryl A Halter; Alice Rudolph; Cliff W Shults; William C Nichols; Tatiana Foroud
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

6.  Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008.

Authors:  Xinzhi Zhang; Kai McKeever Bullard; Mary Frances Cotch; M Roy Wilson; Barry W Rovner; Gerald McGwin; Cynthia Owsley; Lawrence Barker; John E Crews; Jinan B Saaddine
Journal:  JAMA Ophthalmol       Date:  2013-05       Impact factor: 7.389

7.  Telephone-administered cognitive behavioral therapy: a case study of anxiety and depression in Parkinson's disease.

Authors:  Connie Veazey; Karon F Cook; Melinda Stanley; Eugene C Lai; Mark E Kunik
Journal:  J Clin Psychol Med Settings       Date:  2009-04-29

8.  Pattern of depressive symptoms in Parkinson's disease.

Authors:  Amy H Farabaugh; Joseph J Locascio; Liang Yap; Daniel Weintraub; William M McDonald; Monica Agoston; Jonathan E Alpert; John Growdon; Maurizio Fava
Journal:  Psychosomatics       Date:  2009 Sep-Oct       Impact factor: 2.386

9.  Alpha-synuclein and familial Parkinson's disease.

Authors:  Nathan Pankratz; William C Nichols; Veronika E Elsaesser; Michael W Pauciulo; Diane K Marek; Cheryl A Halter; Joanne Wojcieszek; Alice Rudolph; Ronald F Pfeiffer; Tatiana Foroud
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

Review 10.  Decision making in Parkinson's disease: An analysis of the studies using the Iowa Gambling Task.

Authors:  Laura Colautti; Paola Iannello; Maria Caterina Silveri; Alessandro Antonietti
Journal:  Eur J Neurosci       Date:  2021-11-09       Impact factor: 3.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.